Citation 6439

KASHIWADA,Y: SEKIYA,M: YAMAZAKI,K: IKESHIRO,Y: FUJIOKA,T: YAMAGISHI,T: KITAGAWA,S: TAKAISHI,Y:. (2007). TRITERPENOIDS FROM THE FLORAL SPIKES OF BETULA PLATYPHYLLA VAR. JAPONICA AND THEIR REVERSING ACTIVITY AGAINST MULTIDRUG-RESISTANT CANCER CELLS. 70(4)

Citation Details

Title	TRITERPENOIDS FROM THE FLORAL SPIKES OF BETULA PLATYPHYLLA VAR. JAPONICA AND THEIR REVERSING ACTIVITY AGAINST MULTIDRUG-RESISTANT CANCER CELLS
Authors	KASHIWADA,Y: SEKIYA,M: YAMAZAKI,K: IKESHIRO,Y: FUJIOKA,T: YAMAGISHI,T: KITAGAWA,S: TAKAISHI,Y:
Year	2007
Volume	70
Issue	4

Summary

Year: 2007

Journal: Unknown

Organisms and Their Experiments (1)

Betula platyphylla (BETULACEAE)

Experiment #	Pharmacology Type	Worktypes	Compound	Results
1	Not specified	VOUCHER SPECIMEN REPORTED FORMASS-SPECTRAL FRAGMENTATION REPORTEDPMR SPECTRUM REPORTEDCMR SPECTRUM REPORTEDISOLATION OF A COMPOUND WITH NOVEL STRUCTURE	OLEAN-4(23)-13(18)-DIEN-3-OIC ACID,3-4-SECO:	None
2	Not specified	MASS-SPECTRAL FRAGMENTATION REPORTEDPMR SPECTRUM REPORTEDCMR SPECTRUM REPORTEDISOLATION OF A COMPOUND WITH NOVEL STRUCTURE	OLEAN-4(23)-20(30)-DIEN-3-OIC ACID,3-4-SECO-URS:	None
3	Not specified	MASS-SPECTRAL FRAGMENTATION REPORTEDPMR SPECTRUM REPORTEDCMR SPECTRUM REPORTEDISOLATION OF A COMPOUND WITH NOVEL STRUCTURE	OCOTILLOL,EPI II: 3-O-METHYL-MALONYL:	None
4	Not specified	MASS-SPECTRAL FRAGMENTATION REPORTEDPMR SPECTRUM REPORTEDCMR SPECTRUM REPORTEDISOLATION OF A COMPOUND WITH NOVEL STRUCTURE	CABRALEA-HYDROXYLACTONE,3-O-METHYL-MALONYL:	None
5	Not specified	ISOLATION AND IDENTIFICATION OF	DAMMARENONE II,HYDROXY:PAPYRIFERIC ACIDCABRALEONEOCOTILLOL,3-EPI: 3-MALONIC ACID ESTEROCOTILLOL,3-EPI:OCOTILLOL,3-EPI: ACETATE:DAMMARANE,12-ALPHA-ACETOXY-20(S)-24(R)-EPOXY-3R-25-DIHYDROXY:PAPYRIFERATE, METHYL:DAMMARANE,3R-12-ALPHA-DIACETOXY-20(S)-24(R)-EPOXY-25-HYDROXY:SHOREATE, METHYL:DAMMARA-26-EN-3-ONE,20(S)-24(S)-DIHYDROXY:OCOTILLONEBETULONIC ACIDHOPANONE,HYDROXY:CABRALEALACTONECABRALEA-HYDROXYLACTONE	None
6	CYTOTOXIC ACTIVITY	PHARMACOLOGY OF EXTRACT - IN VITRO	None	INACTIVE
7	MULTIDRUG RESISTANCE ENHANCEMENT	PHARMACOLOGY OF EXTRACT - IN VITRO	None	ACTIVE
8	CYTOTOXIC ACTIVITY	PHARMACOLOGY OF COMPOUND - IN VITRO	DAMMARENONE II,HYDROXY:OCOTILLOL,3-EPI: 3-MALONIC ACID ESTEROLEAN-4(23)-20(30)-DIEN-3-OIC ACID,3-4-SECO-URS:DAMMARANE,3R-12-ALPHA-DIACETOXY-20(S)-24(R)-EPOXY-25-HYDROXY:SHOREATE, METHYL:HOPANONE,HYDROXY:CABRALEALACTONE	INACTIVE
10	CYTOTOXIC ACTIVITY	PHARMACOLOGY OF COMPOUND - IN VITRO	OLEAN-4(23)-13(18)-DIEN-3-OIC ACID,3-4-SECO:	INACTIVE
12	CYTOTOXIC ACTIVITY	PHARMACOLOGY OF COMPOUND - IN VITRO	OCOTILLOL,3-EPI:	INACTIVE
13	CYTOTOXIC ACTIVITY	PHARMACOLOGY OF COMPOUND - IN VITRO	OCOTILLOL,EPI II: 3-O-METHYL-MALONYL:	INACTIVE
14	CYTOTOXIC ACTIVITY	PHARMACOLOGY OF COMPOUND - IN VITRO	OCOTILLOL,3-EPI: ACETATE:	INACTIVE
15	CYTOTOXIC ACTIVITY	PHARMACOLOGY OF COMPOUND - IN VITRO	CABRALEA-HYDROXYLACTONE,3-O-METHYL-MALONYL:	INACTIVE
16	CYTOTOXIC ACTIVITY	PHARMACOLOGY OF COMPOUND - IN VITRO	OCOTILLONE	WEAK ACTIVITY
17	CYTOTOXIC ACTIVITY	PHARMACOLOGY OF COMPOUND - IN VITRO	DAMMARANE,12-ALPHA-ACETOXY-20(S)-24(R)-EPOXY-3R-25-DIHYDROXY:	INACTIVE
18	CYTOTOXIC ACTIVITY	PHARMACOLOGY OF COMPOUND - IN VITRO	PAPYRIFERIC ACID	WEAK ACTIVITY
19	CYTOTOXIC ACTIVITY	PHARMACOLOGY OF COMPOUND - IN VITRO	PAPYRIFERATE, METHYL:	INACTIVE
20	CYTOTOXIC ACTIVITY	PHARMACOLOGY OF COMPOUND - IN VITRO	CABRALEONE	INACTIVE
21	CYTOTOXIC ACTIVITY	PHARMACOLOGY OF COMPOUND - IN VITRO	CABRALEA-HYDROXYLACTONE	WEAK ACTIVITY
22	CYTOTOXIC ACTIVITY	PHARMACOLOGY OF COMPOUND - IN VITRO	BETULONIC ACID	ACTIVE
23	CYTOTOXIC ACTIVITY	PHARMACOLOGY OF COMPOUND - IN VITRO	DAMMARA-26-EN-3-ONE,20(S)-24(S)-DIHYDROXY:	INACTIVE
25	MULTIDRUG RESISTANCE ENHANCEMENT	PHARMACOLOGY OF COMPOUND - IN VITRO	HOPANONE,HYDROXY:	EQUIVOCAL
26	MULTIDRUG RESISTANCE ENHANCEMENT	PHARMACOLOGY OF COMPOUND - IN VITRO	OLEAN-4(23)-20(30)-DIEN-3-OIC ACID,3-4-SECO-URS:	ACTIVE
27	MULTIDRUG RESISTANCE ENHANCEMENT	PHARMACOLOGY OF COMPOUND - IN VITRO	OCOTILLOL,3-EPI:	ACTIVE
28	MULTIDRUG RESISTANCE ENHANCEMENT	PHARMACOLOGY OF COMPOUND - IN VITRO	OCOTILLOL,EPI II: 3-O-METHYL-MALONYL:	ACTIVE
29	MULTIDRUG RESISTANCE ENHANCEMENT	PHARMACOLOGY OF COMPOUND - IN VITRO	OCOTILLOL,3-EPI: ACETATE:	INACTIVE
30	MULTIDRUG RESISTANCE ENHANCEMENT	PHARMACOLOGY OF COMPOUND - IN VITRO	CABRALEA-HYDROXYLACTONE,3-O-METHYL-MALONYL:	ACTIVE
31	MULTIDRUG RESISTANCE ENHANCEMENT	PHARMACOLOGY OF COMPOUND - IN VITRO	OCOTILLOL,3-EPI: 3-MALONIC ACID ESTER	ACTIVE
32	MULTIDRUG RESISTANCE ENHANCEMENT	PHARMACOLOGY OF COMPOUND - IN VITRO	OCOTILLONE	ACTIVE
33	MULTIDRUG RESISTANCE ENHANCEMENT	PHARMACOLOGY OF COMPOUND - IN VITRO	DAMMARANE,12-ALPHA-ACETOXY-20(S)-24(R)-EPOXY-3R-25-DIHYDROXY:	INACTIVE
34	MULTIDRUG RESISTANCE ENHANCEMENT	PHARMACOLOGY OF COMPOUND - IN VITRO	PAPYRIFERIC ACID	ACTIVE
35	MULTIDRUG RESISTANCE ENHANCEMENT	PHARMACOLOGY OF COMPOUND - IN VITRO	PAPYRIFERATE, METHYL:	ACTIVE
36	MULTIDRUG RESISTANCE ENHANCEMENT	PHARMACOLOGY OF COMPOUND - IN VITRO	DAMMARANE,3R-12-ALPHA-DIACETOXY-20(S)-24(R)-EPOXY-25-HYDROXY:	ACTIVE
37	MULTIDRUG RESISTANCE ENHANCEMENT	PHARMACOLOGY OF COMPOUND - IN VITRO	CABRALEONE	ACTIVE
38	MULTIDRUG RESISTANCE ENHANCEMENT	PHARMACOLOGY OF COMPOUND - IN VITRO	SHOREATE, METHYL:	ACTIVE
39	MULTIDRUG RESISTANCE ENHANCEMENT	PHARMACOLOGY OF COMPOUND - IN VITRO	CABRALEALACTONE	ACTIVE
40	MULTIDRUG RESISTANCE ENHANCEMENT	PHARMACOLOGY OF COMPOUND - IN VITRO	CABRALEA-HYDROXYLACTONE	ACTIVE
41	MULTIDRUG RESISTANCE ENHANCEMENT	PHARMACOLOGY OF COMPOUND - IN VITRO	BETULONIC ACID	ACTIVE
42	MULTIDRUG RESISTANCE ENHANCEMENT	PHARMACOLOGY OF COMPOUND - IN VITRO	DAMMARA-26-EN-3-ONE,20(S)-24(S)-DIHYDROXY:	ACTIVE
43	MULTIDRUG RESISTANCE ENHANCEMENT	PHARMACOLOGY OF COMPOUND - IN VITRO	DAMMARENONE II,HYDROXY:	ACTIVE

Citation 6439

Citation Details

Summary

Organisms and Their Experiments (1)

Betula platyphylla (BETULACEAE)

Show SPARQL Queries (1)

Query 1